These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16461769)

  • 1. Calpain is required for normal osteoclast function and is down-regulated by calcitonin.
    Marzia M; Chiusaroli R; Neff L; Kim NY; Chishti AH; Baron R; Horne WC
    J Biol Chem; 2006 Apr; 281(14):9745-54. PubMed ID: 16461769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities.
    Shyu JF; Shih C; Tseng CY; Lin CH; Sun DT; Liu HT; Tsung HC; Chen TH; Lu RB
    Bone; 2007 May; 40(5):1329-42. PubMed ID: 17321230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.
    Kuo YJ; Tsuang FY; Sun JS; Lin CH; Chen CH; Li JY; Huang YC; Chen WY; Yeh CB; Shyu JF
    PLoS One; 2012; 7(7):e40272. PubMed ID: 22792258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption.
    Biswas RS; Baker D; Hruska KA; Chellaiah MA
    BMC Cell Biol; 2004 May; 5():19. PubMed ID: 15142256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate.
    Yaroslavskiy BB; Turkova I; Wang Y; Robinson LJ; Blair HC
    Lab Invest; 2010 Oct; 90(10):1533-42. PubMed ID: 20567233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of osteoclasts by calcitonin and amphiphilic calcitonin conjugates: role of cytosolic calcium.
    Komarova SV; Shum JB; Paige LA; Sims SM; Dixon SJ
    Calcif Tissue Int; 2003 Sep; 73(3):265-73. PubMed ID: 14667140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts.
    Alam AS; Moonga BS; Bevis PJ; Huang CL; Zaidi M
    Exp Physiol; 1993 Mar; 78(2):183-96. PubMed ID: 8385961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of calcitonin on osteoclast].
    Yamamoto Y; Noguchi T; Takahashi N
    Clin Calcium; 2005 Mar; 15(3):147-51. PubMed ID: 15741694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of calpain in osteoclastic bone resorption.
    Hayashi M; Koshihara Y; Ishibashi H; Yamamoto S; Tsubuki S; Saido TC; Kawashima S; Inomata M
    J Biochem; 2005 Mar; 137(3):331-8. PubMed ID: 15809334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.
    Li X; Ye JX; Xu MH; Zhao MD; Yuan FL
    Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RhoGAP activity of myosin IXB is critical for osteoclast podosome patterning, motility, and resorptive capacity.
    McMichael BK; Scherer KF; Franklin NC; Lee BS
    PLoS One; 2014; 9(1):e87402. PubMed ID: 24466350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin-like effects of forskolin and choleratoxin on surface area and motility of isolated rabbit osteoclasts.
    Ransjö M; Lerner UH; Heersche JN
    J Bone Miner Res; 1988 Dec; 3(6):611-9. PubMed ID: 3251398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.
    Lakkakorpi PT; Väänänen HK
    J Bone Miner Res; 1991 Aug; 6(8):817-26. PubMed ID: 1664645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice.
    Gil-Henn H; Destaing O; Sims NA; Aoki K; Alles N; Neff L; Sanjay A; Bruzzaniti A; De Camilli P; Baron R; Schlessinger J
    J Cell Biol; 2007 Sep; 178(6):1053-64. PubMed ID: 17846174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetraspanin 7 regulates sealing zone formation and the bone-resorbing activity of osteoclasts.
    Kwon JO; Lee YD; Kim H; Kim MK; Song MK; Lee ZH; Kim HH
    Biochem Biophys Res Commun; 2016 Sep; 477(4):1078-1084. PubMed ID: 27416754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
    Samura A; Wada S; Suda S; Iitaka M; Katayama S
    Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.